{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:11:54Z","timestamp":1791490314510,"version":"4.3.4"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6590","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T22:05:53Z","timestamp":1463263553000},"page":"1375-1378","source":"Crossref","is-referenced-by-count":10,"title":["Successful Treatment with Adalimumab for Intestinal Behcet's Disease during Pregnancy"],"prefix":"10.2169","volume":"55","author":[{"given":"Keita","family":"Fujikawa","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Mizokami","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Tabuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Ohba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Unit of Translational Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 341: 1284-1291, 1999.","DOI":"10.1056\/NEJM199910213411707"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Iwata S, Saito K, Yamaoka K, et al. Effects of anti-TNF-α antibody infliximab in refractory entero-Behçet's disease. Rheumatology (Oxford) 48: 1012-1013, 2009.","DOI":"10.1093\/rheumatology\/kep126"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Iwata S, Saito K, Yamaoka K, et al. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease. Mod Rheumatol 21: 184-191, 2011.","DOI":"10.3109\/s10165-010-0370-y"},{"key":"4","unstructured":"4. Hisamatsu T, Ueno F, Matsumoto T, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behcet's disease: indication of anti-TNFα monoclonal antibodies. J Gastroenterol 49: 156-162, 2014."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hazes JM, Coulie PG, Geenen V, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford) 50: 1955-1968, 2011.","DOI":"10.1093\/rheumatology\/ker302"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Marchioni RM, Lichtenstein GR. Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review. World J Gastroenterol 19: 2591-2602, 2013.","DOI":"10.3748\/wjg.v19.i17.2591"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Song YW, Kang EH. Behcet's disease and genes within the major histocompatibility complex region. Mod Rheumatol 22: 178-185, 2012.","DOI":"10.3109\/s10165-011-0542-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 67: 1656-1662, 2008.","DOI":"10.1136\/ard.2007.080432"},{"key":"9","unstructured":"9. Ben-Chetrit E. Behcet's syndrome and pregnancy: course of the disease and pregnancy outcome. Clin Exp Rheumatol 32 (4 Suppl 84): S93-S98, 2014."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 18: 735-742, 1983.","DOI":"10.3109\/00365528309182088"},{"key":"11","unstructured":"11. Morales M, Berney T, Jenny A, Morel P, Extermann P. Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 47: 1595-1598, 2000."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 15: 237-241, 2004.","DOI":"10.1080\/14767050410001668662"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hutson JR, Matlow JN, Moretti ME, Koren G. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol 33: 1-8, 2013.","DOI":"10.3109\/01443615.2012.716106"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 19: 15-22, 2013.","DOI":"10.1002\/ibd.22948"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36: 248-255, 1996.","DOI":"10.1111\/j.1600-0897.1996.tb00172.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mahadevan U, Wolf DC, Dubinsky M, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11: 286-292, 2013.","DOI":"10.1016\/j.cgh.2012.11.011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Murashima A, Watanabe N, Ozawa N, Saito H, Yamaguchi K. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 68: 1793-1794, 2009.","DOI":"10.1136\/ard.2008.105924"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 4: 603-605, 2010.","DOI":"10.1016\/j.crohns.2010.05.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gisbert JP, Chaparro M. Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. Am J Gastroenterol 108: 1426-1438, 2013.","DOI":"10.1038\/ajg.2013.171"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.6590\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:42:12Z","timestamp":1498311732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.6590\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6590","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}